Free Trial

Cadre (CDRE) Competitors

Cadre logo
$31.27 -0.30 (-0.95%)
Closing price 03:58 PM Eastern
Extended Trading
$31.32 +0.05 (+0.16%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDRE vs. INSP, NARI, PRCT, IRTC, NVST, TMDX, SLNO, ENOV, LIVN, and NVCR

Should you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Envista (NVST), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Enovis (ENOV), LivaNova (LIVN), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.

Cadre vs.

Inspire Medical Systems (NYSE:INSP) and Cadre (NYSE:CDRE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Inspire Medical Systems has a net margin of 6.67% compared to Cadre's net margin of 6.34%. Cadre's return on equity of 12.88% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems6.67% 8.19% 7.09%
Cadre 6.34%12.88%6.06%

Inspire Medical Systems has higher revenue and earnings than Cadre. Cadre is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$802.80M6.13$53.51M$1.7395.60
Cadre$567.56M2.24$38.64M$0.9034.74

Inspire Medical Systems has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.

Inspire Medical Systems received 177 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 61.66% of users gave Inspire Medical Systems an outperform vote while only 55.17% of users gave Cadre an outperform vote.

CompanyUnderperformOutperform
Inspire Medical SystemsOutperform Votes
193
61.66%
Underperform Votes
120
38.34%
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%

Inspire Medical Systems currently has a consensus price target of $228.82, indicating a potential upside of 38.36%. Cadre has a consensus price target of $37.00, indicating a potential upside of 18.32%. Given Inspire Medical Systems' higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Cadre
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Cadre had 9 more articles in the media than Inspire Medical Systems. MarketBeat recorded 11 mentions for Cadre and 2 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.51 beat Cadre's score of 0.66 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Cadre
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Inspire Medical Systems beats Cadre on 14 of the 18 factors compared between the two stocks.

Remove Ads
Get Cadre News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDRE vs. The Competition

MetricCadreSurgical appliances & supplies IndustryIndustrials SectorNYSE Exchange
Market Cap$1.27B$9.14B$7.08B$19.75B
Dividend Yield1.18%1.41%3.54%3.75%
P/E Ratio37.6717.6821.0334.05
Price / Sales2.2470.0574.1028.57
Price / Cash22.8919.6726.8317.54
Price / Book5.965.653.744.63
Net Income$38.64M$284.66M$793.45M$1.02B
7 Day Performance-3.48%2.33%0.07%1.12%
1 Month Performance-6.38%-1.93%0.15%-1.07%
1 Year Performance-9.88%-15.84%28.79%7.08%

Cadre Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDRE
Cadre
3.1257 of 5 stars
$31.27
-1.0%
$37.00
+18.3%
-9.0%$1.27B$567.56M37.672,240Insider Trade
INSP
Inspire Medical Systems
4.7036 of 5 stars
$170.89
+3.6%
$228.82
+33.9%
-13.4%$5.09B$802.80M98.781,246Positive News
NARI
Inari Medical
0.936 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
PRCT
PROCEPT BioRobotics
3.0601 of 5 stars
$60.90
+4.8%
$94.29
+54.8%
+27.8%$3.34B$224.50M-31.23430News Coverage
IRTC
iRhythm Technologies
1.5315 of 5 stars
$105.86
+1.3%
$119.73
+13.1%
-2.3%$3.33B$591.84M-29.081,790Positive News
Gap Up
NVST
Envista
4.1292 of 5 stars
$17.51
+5.1%
$20.18
+15.3%
-17.9%$3.01B$2.51B-2.7012,700
TMDX
TransMedics Group
3.051 of 5 stars
$71.47
+3.5%
$122.70
+71.7%
+0.9%$2.41B$441.54M76.03210
SLNO
Soleno Therapeutics
4.4317 of 5 stars
$50.14
+2.1%
$71.20
+42.0%
+19.4%$2.30BN/A-15.1030
ENOV
Enovis
2.8272 of 5 stars
$40.01
+2.4%
$58.50
+46.2%
-33.5%$2.28B$2.11B-18.276,550Positive News
LIVN
LivaNova
4.2276 of 5 stars
$40.37
+2.3%
$61.17
+51.5%
-27.9%$2.19B$1.25B96.122,900Positive News
NVCR
NovoCure
3.6151 of 5 stars
$19.78
+2.3%
$35.80
+81.0%
+49.7%$2.17B$605.22M-14.131,320Positive News
Remove Ads

Related Companies and Tools


This page (NYSE:CDRE) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners